switching model of the four-phase boost converters Search Results


bia multifrequencial four-phase bioimpedance body model 520  (Biospace Co Ltd)
90
Biospace Co Ltd bia multifrequencial four-phase bioimpedance body model 520
Bia Multifrequencial Four Phase Bioimpedance Body Model 520, supplied by Biospace Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bia multifrequencial four-phase bioimpedance body model 520/product/Biospace Co Ltd
Average 90 stars, based on 1 article reviews
bia multifrequencial four-phase bioimpedance body model 520 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
four-phase stepper motor stmicroelectronics l298n  (STMicroelectronics Pte)
90
STMicroelectronics Pte four-phase stepper motor stmicroelectronics l298n
Four Phase Stepper Motor Stmicroelectronics L298n, supplied by STMicroelectronics Pte, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/four-phase stepper motor stmicroelectronics l298n/product/STMicroelectronics Pte
Average 90 stars, based on 1 article reviews
four-phase stepper motor stmicroelectronics l298n - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
reversible, four-phase stepper motor rs 440-284  (RS Components)
90
RS Components reversible, four-phase stepper motor rs 440-284
Reversible, Four Phase Stepper Motor Rs 440 284, supplied by RS Components, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reversible, four-phase stepper motor rs 440-284/product/RS Components
Average 90 stars, based on 1 article reviews
reversible, four-phase stepper motor rs 440-284 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
four-phase ct scan aquilion 64  (Toshiba America Electronic Components Inc)
90
Toshiba America Electronic Components Inc four-phase ct scan aquilion 64
Four Phase Ct Scan Aquilion 64, supplied by Toshiba America Electronic Components Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/four-phase ct scan aquilion 64/product/Toshiba America Electronic Components Inc
Average 90 stars, based on 1 article reviews
four-phase ct scan aquilion 64 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
four-phase 320-detector row ct aquilion one  (Canon inc)
90
Canon inc four-phase 320-detector row ct aquilion one
Four Phase 320 Detector Row Ct Aquilion One, supplied by Canon inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/four-phase 320-detector row ct aquilion one/product/Canon inc
Average 90 stars, based on 1 article reviews
four-phase 320-detector row ct aquilion one - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
biotage isolera four  (BIOTAGE)
90
BIOTAGE biotage isolera four
Biotage Isolera Four, supplied by BIOTAGE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biotage isolera four/product/BIOTAGE
Average 90 stars, based on 1 article reviews
biotage isolera four - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
beam splitters layertec  (Layertec GmbH)
90
Layertec GmbH beam splitters layertec
Beam Splitters Layertec, supplied by Layertec GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/beam splitters layertec/product/Layertec GmbH
Average 90 stars, based on 1 article reviews
beam splitters layertec - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
tc-5214  (AstraZeneca ltd)
90
AstraZeneca ltd tc-5214
Tc 5214, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tc-5214/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
tc-5214 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
tc-5214  (Targacept)
90
Targacept tc-5214
Tc 5214, supplied by Targacept, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tc-5214/product/Targacept
Average 90 stars, based on 1 article reviews
tc-5214 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
500 w, four-phase, 8/6 pole srm  (ANSYS inc)
90
ANSYS inc 500 w, four-phase, 8/6 pole srm
500 W, Four Phase, 8/6 Pole Srm, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/500 w, four-phase, 8/6 pole srm/product/ANSYS inc
Average 90 stars, based on 1 article reviews
500 w, four-phase, 8/6 pole srm - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
ex-rad  (Onconova Inc)
90
Onconova Inc ex-rad
Ex Rad, supplied by Onconova Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ex-rad/product/Onconova Inc
Average 90 stars, based on 1 article reviews
ex-rad - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
faricimab  (Tenaya Therapeutics)
90
Tenaya Therapeutics faricimab
Schematic of the model for ocular and systemic pharmacokinetics of <t>faricimab.</t> AH, aqueous humor; CL, clearance; IVT, intravitreal; k, elimination rate; k AH , elimination rate constant for AH; k VH , elimination rate constant for VH; V A , volume of the AH compartment; V C , volume of the plasma compartment; V H , volume of the VH compartment; VH, vitreous humor.
Faricimab, supplied by Tenaya Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/faricimab/product/Tenaya Therapeutics
Average 90 stars, based on 1 article reviews
faricimab - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Schematic of the model for ocular and systemic pharmacokinetics of faricimab. AH, aqueous humor; CL, clearance; IVT, intravitreal; k, elimination rate; k AH , elimination rate constant for AH; k VH , elimination rate constant for VH; V A , volume of the AH compartment; V C , volume of the plasma compartment; V H , volume of the VH compartment; VH, vitreous humor.

Journal: Translational Vision Science & Technology

Article Title: Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease

doi: 10.1167/tvst.13.11.14

Figure Lengend Snippet: Schematic of the model for ocular and systemic pharmacokinetics of faricimab. AH, aqueous humor; CL, clearance; IVT, intravitreal; k, elimination rate; k AH , elimination rate constant for AH; k VH , elimination rate constant for VH; V A , volume of the AH compartment; V C , volume of the plasma compartment; V H , volume of the VH compartment; VH, vitreous humor.

Article Snippet: Faricimab was studied in four phase 3 studies, which assessed the safety and efficacy of faricimab administered up to every 16 weeks (Q16W) in patients with nAMD (TENAYA and LUCERNE) and DME (YOSEMITE and RHINE).

Techniques: Drug discovery, Clinical Proteomics

Individual faricimab concentrations versus time after most recent dose in patients with nAMD and DME (pooled) and patients with nAMD or DME. The asterisks (*) indicate below the limit of quantification; green circle s , faricimab 0.5 mg; red circle s , faricimab 1.5 mg; blue circle s , faricimab 3.0 mg; black circle s , faricimab 6.0 mg. DME, diabetic macular edema; nAMD, neovascular age-related macular degeneration.

Journal: Translational Vision Science & Technology

Article Title: Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease

doi: 10.1167/tvst.13.11.14

Figure Lengend Snippet: Individual faricimab concentrations versus time after most recent dose in patients with nAMD and DME (pooled) and patients with nAMD or DME. The asterisks (*) indicate below the limit of quantification; green circle s , faricimab 0.5 mg; red circle s , faricimab 1.5 mg; blue circle s , faricimab 3.0 mg; black circle s , faricimab 6.0 mg. DME, diabetic macular edema; nAMD, neovascular age-related macular degeneration.

Article Snippet: Faricimab was studied in four phase 3 studies, which assessed the safety and efficacy of faricimab administered up to every 16 weeks (Q16W) in patients with nAMD (TENAYA and LUCERNE) and DME (YOSEMITE and RHINE).

Techniques:

Parameter Estimates for the Faricimab Population Pharmacokinetic Model

Journal: Translational Vision Science & Technology

Article Title: Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease

doi: 10.1167/tvst.13.11.14

Figure Lengend Snippet: Parameter Estimates for the Faricimab Population Pharmacokinetic Model

Article Snippet: Faricimab was studied in four phase 3 studies, which assessed the safety and efficacy of faricimab administered up to every 16 weeks (Q16W) in patients with nAMD (TENAYA and LUCERNE) and DME (YOSEMITE and RHINE).

Techniques: Clinical Proteomics

Faricimab Steady-State Exposure Estimates Following 6-mg Q8W Dosing in Phase 3 Studies

Journal: Translational Vision Science & Technology

Article Title: Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease

doi: 10.1167/tvst.13.11.14

Figure Lengend Snippet: Faricimab Steady-State Exposure Estimates Following 6-mg Q8W Dosing in Phase 3 Studies

Article Snippet: Faricimab was studied in four phase 3 studies, which assessed the safety and efficacy of faricimab administered up to every 16 weeks (Q16W) in patients with nAMD (TENAYA and LUCERNE) and DME (YOSEMITE and RHINE).

Techniques: Clinical Proteomics